Cargando…
Current Knowledge about Providing Drug–Drug Interaction Services for Patients—A Scoping Review
Drug–drug interactions (DDIs) pose a major problem to patient safety. eHealth solutions have the potential to address this problem and generally improve medication management by providing digital services for health care professionals and patients. Clinical decision support systems (CDSS) to alert p...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103271/ https://www.ncbi.nlm.nih.gov/pubmed/33805205 http://dx.doi.org/10.3390/pharmacy9020069 |
_version_ | 1783689286301777920 |
---|---|
author | Hammar, Tora Hamqvist, Sara Zetterholm, My Jokela, Päivi Ferati, Mexhid |
author_facet | Hammar, Tora Hamqvist, Sara Zetterholm, My Jokela, Päivi Ferati, Mexhid |
author_sort | Hammar, Tora |
collection | PubMed |
description | Drug–drug interactions (DDIs) pose a major problem to patient safety. eHealth solutions have the potential to address this problem and generally improve medication management by providing digital services for health care professionals and patients. Clinical decision support systems (CDSS) to alert physicians or pharmacists about DDIs are common, and there is an extensive body of research about CDSS for professionals. Information about DDIs is commonly requested by patients, but little is known about providing similar support to patients. The aim of this scoping review was to explore and describe current knowledge about providing digital DDI services for patients. Using a broad search strategy and an established framework for scoping reviews, 19 papers were included. The results show that although some patients want to check for DDIs themselves, there are differences between patients, in terms of demands and ability. There are numerous DDI services available, but the existence of large variations regarding service quality implies potential safety issues. The review includes suggestions about design features but also indicates a substantial knowledge gap highlighting the need for further research about how to best design and provide digital DDI to patients without risking patient safety or having other unintended consequences. |
format | Online Article Text |
id | pubmed-8103271 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81032712021-05-08 Current Knowledge about Providing Drug–Drug Interaction Services for Patients—A Scoping Review Hammar, Tora Hamqvist, Sara Zetterholm, My Jokela, Päivi Ferati, Mexhid Pharmacy (Basel) Review Drug–drug interactions (DDIs) pose a major problem to patient safety. eHealth solutions have the potential to address this problem and generally improve medication management by providing digital services for health care professionals and patients. Clinical decision support systems (CDSS) to alert physicians or pharmacists about DDIs are common, and there is an extensive body of research about CDSS for professionals. Information about DDIs is commonly requested by patients, but little is known about providing similar support to patients. The aim of this scoping review was to explore and describe current knowledge about providing digital DDI services for patients. Using a broad search strategy and an established framework for scoping reviews, 19 papers were included. The results show that although some patients want to check for DDIs themselves, there are differences between patients, in terms of demands and ability. There are numerous DDI services available, but the existence of large variations regarding service quality implies potential safety issues. The review includes suggestions about design features but also indicates a substantial knowledge gap highlighting the need for further research about how to best design and provide digital DDI to patients without risking patient safety or having other unintended consequences. MDPI 2021-03-24 /pmc/articles/PMC8103271/ /pubmed/33805205 http://dx.doi.org/10.3390/pharmacy9020069 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Review Hammar, Tora Hamqvist, Sara Zetterholm, My Jokela, Päivi Ferati, Mexhid Current Knowledge about Providing Drug–Drug Interaction Services for Patients—A Scoping Review |
title | Current Knowledge about Providing Drug–Drug Interaction Services for Patients—A Scoping Review |
title_full | Current Knowledge about Providing Drug–Drug Interaction Services for Patients—A Scoping Review |
title_fullStr | Current Knowledge about Providing Drug–Drug Interaction Services for Patients—A Scoping Review |
title_full_unstemmed | Current Knowledge about Providing Drug–Drug Interaction Services for Patients—A Scoping Review |
title_short | Current Knowledge about Providing Drug–Drug Interaction Services for Patients—A Scoping Review |
title_sort | current knowledge about providing drug–drug interaction services for patients—a scoping review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103271/ https://www.ncbi.nlm.nih.gov/pubmed/33805205 http://dx.doi.org/10.3390/pharmacy9020069 |
work_keys_str_mv | AT hammartora currentknowledgeaboutprovidingdrugdruginteractionservicesforpatientsascopingreview AT hamqvistsara currentknowledgeaboutprovidingdrugdruginteractionservicesforpatientsascopingreview AT zetterholmmy currentknowledgeaboutprovidingdrugdruginteractionservicesforpatientsascopingreview AT jokelapaivi currentknowledgeaboutprovidingdrugdruginteractionservicesforpatientsascopingreview AT feratimexhid currentknowledgeaboutprovidingdrugdruginteractionservicesforpatientsascopingreview |